By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded startup NanoSort a two-year, $297,000 Small Business Innovation Research (SBIR) grant, as well as a nine-month, $198,000 contract. NanoSort will use the funds to develop devices to detect circulating tumor cells using two different approaches. The San Diego-based firm applies lab-on-a-chip technologies to drastically reduce the size and cost of flow cytometers while maintaining high performance., it said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.